Cargando…

Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy

Detalles Bibliográficos
Autores principales: Shamash, J, Oliver, R T D, Gallagher, C J, Newland, A C, Lister, T A, Kelsey, S, Gupta, R K, O'Doherty, C A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363262/
https://www.ncbi.nlm.nih.gov/pubmed/10864212
http://dx.doi.org/10.1054/bjoc.1999.1140
_version_ 1782153659961835520
author Shamash, J
Oliver, R T D
Gallagher, C J
Newland, A C
Lister, T A
Kelsey, S
Gupta, R K
O'Doherty, C A
author_facet Shamash, J
Oliver, R T D
Gallagher, C J
Newland, A C
Lister, T A
Kelsey, S
Gupta, R K
O'Doherty, C A
author_sort Shamash, J
collection PubMed
description
format Text
id pubmed-2363262
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23632622009-09-10 Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy Shamash, J Oliver, R T D Gallagher, C J Newland, A C Lister, T A Kelsey, S Gupta, R K O'Doherty, C A Br J Cancer Letters to the Editor Nature Publishing Group 2000-06 2000-05-18 /pmc/articles/PMC2363262/ /pubmed/10864212 http://dx.doi.org/10.1054/bjoc.1999.1140 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letters to the Editor
Shamash, J
Oliver, R T D
Gallagher, C J
Newland, A C
Lister, T A
Kelsey, S
Gupta, R K
O'Doherty, C A
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
title Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
title_full Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
title_fullStr Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
title_full_unstemmed Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
title_short Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
title_sort pre-induction ldh as a prognostic factor for outcome of high dose chemotherapy (hdct) for germ cell tumours relapsing or refractory to conventional chemotherapy
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363262/
https://www.ncbi.nlm.nih.gov/pubmed/10864212
http://dx.doi.org/10.1054/bjoc.1999.1140
work_keys_str_mv AT shamashj preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy
AT oliverrtd preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy
AT gallaghercj preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy
AT newlandac preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy
AT listerta preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy
AT kelseys preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy
AT guptark preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy
AT odohertyca preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy